Renaissance BioScience Corp., a global leader in yeast bioengineering focusing on yeast-produced RNA and virus-like particles, announced the appointment of Dr. James Tansey to its Board of Directors. The move is expected to bolster the company's strategic growth and commercialization efforts across agriculture, animal health, and human health applications.
Dr. Tansey brings a wealth of experience as a serial entrepreneur, research academic, and business leader. He is a professor at the University of British Columbia's Sauder School of Business and previously served on the faculty at Oxford University's Saïd Business School. As a member of the founding team at Gemina Labs, he supports fundraising, business development, and shareholder strategy. He also serves on the boards of dynaCERT Inc. and Vanadium Resources Ltd. and is a Senior Advisor to InBC, British Columbia's $500 million strategic investment fund.
Maurice Boucher, Renaissance Co-Founder and Executive Chairman, expressed enthusiasm about the appointment, stating, "James brings an outstanding combination of entrepreneurial, strategic and governance experience, together with a strong track record of helping innovative technology companies grow." Boucher highlighted Tansey's focus on impact investing and environmental sustainability, which aligns with Renaissance's mission to provide positive environmental impact through its technology platforms.
Dr. Tansey commented on his new role: "Renaissance has developed an impressive portfolio of innovative technologies with significant commercial potential across agriculture, industrial biotechnology and animal and human health. I look forward to working with the Board and management team to help the company execute on its growth strategy and create long-term value."
Dr. John Husnik, Renaissance Co-Founder, Director and CSO, added, "His experience building companies, securing investment, and helping innovative technologies move toward commercialization will complement our scientific expertise and support Renaissance as we continue developing and expanding our leading technology platforms."
Renaissance BioScience Corp., based in Vancouver, Canada, is known for developing functional microorganisms that address environmental and industrial challenges. The appointment of Dr. Tansey signals the company's commitment to accelerating the global commercialization of its biotechnology platforms. For more information about the company and its technologies, visit www.renaissancebioscience.com.
